Martin Verronneau Email & Phone Number

Mont-Tremblant, Qc, Ca

Montreal, Quebec, Canada

ALT 5 Sigma is a global fintech company providing next generation blockchain powered technologies for the tokenization, issuance, trading, clearing, settlement, payment, and custodianship of digital instruments. We are built on the foundation of security, accessibility, compliancy, and transparency.ALT 5 Prime is the complete front, middle and back-office trading platform for registered and approved institutions enabling the buying, selling, and holding of digital assets for their customers.ALT 5 Card is a Visa and Mastercard that is loadable and re-loadable directly from your ALT 5 account balance.ALT 5 Pay is both a Payment Gateway allowing your business to accept digital assets online payments without the risks associated with market volatility, and also a Payment Processor enabling your business to make payments in digital assets.

New York City Metropolitan Area

• Advise emerging growth companies on financing options• Assist clients throughout their development from seed to IPO• Consult clients on Reg CF, Reg A, Private Placement and Tokenization options

Sainte-Adèle, Canada

Founder and land developper of a real estate investment company• Monitoring and commercialization of a $47MM residential development• Management of infrastructure planning and construction• Management of high-end single family dwelling unit planning and construction

Greater Boston Area

Co-founded a Biotechnological & Pharmaceutical products company specializing in Cancer.• Partnership agreement with StageZero Life Sciences labs for their blood-based biomarker tests in early cancer detection• Distribution agreement of BreastSentry® and ColonSentry® in Belgium, the Netherlands, and Luxembourg, valued at $61.8MM

Montreal, Quebec, Canada

Founding Shareholder in charge of Business Development for Inolife Sciences which develops and commercializes a Needle-Free liquid Injector (Inojex) and powder injector (Nanojex). • Designed a Gonadotropin Kinetics and Bio-Equivalence Validation Study followed by a Phase III Study for regulatory approvals and negotiated a partnership agreement with India-based pharmaceutical manufacturer Sanzyme Private Limited for its implementation.• Negotiated distribution agreements in Brazil, Ecuador, Egypt, India, Israel, Saudi Arabia and USA.• Listed the device with Patterson Dental USA for an estimated $38MM in annual revenues. • Helped raise 2.8M in a funding round to subsequently acquired InsuJet and be publicly listed on the TSXV.

Laval, Laurentians, Abitibi And Northen Québec, Canada

Québec And Atlantic, Canada

Montreal, Canada Area

Montreal, Canada Area

Province Of Québec, Canada

• Promote product on plasma volume expansion, anticoagulation and antiparkinson at university teaching hospitals throughout the province to anaesthesiologist, surgeon, cardiologist, haematologist, neurologist and resident• Continuous Medical Education and scientific conferences organization• Target and convince new University center to join a nationwide study• Presentation to P&T committee members to counter the introduction of a generic competitor

Province Of Québec, Canada

• Promote product on hyperhydrosis, infected wound, kidney stones, erectile dysfunction, osteoporosis and flatulence at Montreal’s hospitals to dermatologist, urologist, gynaecologist and gastro-enterologist• Negotiate partnership agreement with local and nationwide wholesaler• Promotion and Continuous Medical Education to pharmacist on product knowledge• Presentation to government officials for formulary coverage of our products

Lacolle Port Of Entry, Canada Area

Montreal, Canada Area

B.Sc., Administration Publique

D.E.C., Droit / Law

D.E.S.